Indiana advocate calls for universal insulin price cap
CRAWFORDSVILLE, Ind. (WISH) — For 13 years, Molly King has depended on an insulin drug to manage her Type 1 diabetes . On Dec. 31, that drug will be wiped from the market .
King, who lives in Crawfordsville , was 18 when she was first diagnosed with Type 1 diabetes. After much work with a medical team, she was prescribed long-acting insulin drug Levemir. She also takes a short-acting insulin medication.
Levemir’s manufacturer announced it would discontinue the drug in 2023. The company cited “manufacturing constraints” at the time of the announcement…